DGX Form 144: Insider reports sales totaling 7,030 shares

Thomas P. Plewman reported sales of common stock via Form 144.

Rhea-AI Filing Summary

Thomas P. Plewman reported sales of common stock via Form 144. The filing lists multiple dispositions: 5,662 shares (sale proceeds $1,155,048.00) on 02/10/2026, 958 shares (proceeds $196,227.14) on 02/19/2026, and 410 shares (proceeds $85,169.30) on 03/03/2026. The excerpt also shows 2,855 shares from a restricted stock vesting entry dated 02/23/2026.

Insights

Insider Transactions Analyst

Insider reported several open‑market dispositions totaling multiple thousands of shares in February–March 2026.

The filing itemizes specific sales: 5,662, 958, and 410 shares with corresponding gross proceeds shown in the excerpt. These entries reflect reported dispositions by Thomas P. Plewman across discrete dates.

Timing and exact sale methods are listed by date but the excerpt does not state whether proceeds were retained by the seller or used for a particular purpose; subsequent filings may provide further detail.

FAQ

What did DGX insider Thomas P. Plewman report on Form 144?

He reported sales of common stock on three dates in Feb–Mar 2026. The filing shows 5,662 shares on 02/10/2026, 958 shares on 02/19/2026, and 410 shares on 03/03/2026, with gross proceeds listed for each sale.

How many shares from restricted stock vesting are shown in the DGX excerpt?

The excerpt lists 2,855 shares tied to restricted stock vesting. That vesting entry is dated 02/23/2026 and is labeled as Compensation in the provided lines.

What monetary proceeds are shown for Plewman's largest reported sale?

The largest reported sale shows proceeds of $1,155,048.00. This amount corresponds to the 5,662-share disposition reported on 02/10/2026 in the excerpt.

Does the filing state how the sales were executed (method or broker)?

The excerpt lists a brokerage name for one entry but does not fully describe execution methods. Fidelity Brokerage Services LLC is shown in the securities section; however, the excerpt does not specify sale methods or whether trades were open‑market or otherwise.

Are these Form 144 entries indicative of company stock issuances?

The entries in the excerpt are reported dispositions, not new issuer share issuances. One line shows restricted stock vesting of 2,855 shares dated 02/23/2026, labeled as Compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 10:43 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001497368
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	QUEST DIAGNOSTICS INC
SEC File Number	001-12215
Address of Issuer	500 PLAZA DRIVE SECAUCUS NEW JERSEY 07094
Phone	9735202700
Name of Person for Whose Account the Securities are To Be Sold	Plewman Patrick
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2855	588729.55	109866320	03/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2026	Restricted Stock Vesting	Issuer			2855	02/23/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Thomas P. Plewman 500 Plaza Drive Secaucus NJ 07094	Common	02/10/2026	5662	1155048.00
Thomas P. Plewman 500 Plaza Drive Secaucus NJ 07094	Common	02/19/2026	958	196227.14
Thomas P. Plewman 500 Plaza Drive Secaucus NJ 07094	Common	03/03/2026	410	85169.30

144: Remarks and Signature

Remarks	Patrick Plewman and Thomas P. Plewman are one and the same person.
Date of Notice	03/05/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/01/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Thomas P. Plewman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)